
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 06, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Olanzapine for Injection, 10 mg/vial, Single-Dose Vial".
Filed with NSE · · 3 pages · English

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 06, 2026, titled "Glenmark Pharmaceuticals Inc., USA launches Olanzapine for Injection, 10 mg/vial, Single-Dose Vial".
Glenmark Pharmaceuticals Limited on 6ix
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals